267 related articles for article (PubMed ID: 29685164)
1. Chemoprophylaxis of leprosy with rifampicin in contacts of multibacillary patients: study protocol for a randomized controlled trial.
Dos Santos DS; Duppre NC; Sarno EN; Pinheiro RO; Sales AM; Nery JADC; Moraes MO; Camacho LAB
Trials; 2018 Apr; 19(1):244. PubMed ID: 29685164
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of single-dose rifampicin after BCG vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: A cluster randomized controlled trial.
Richardus R; Alam K; Kundu K; Chandra Roy J; Zafar T; Chowdhury AS; Nieboer D; Faber R; Butlin CR; Geluk A; Richardus JH
Int J Infect Dis; 2019 Nov; 88():65-72. PubMed ID: 31499206
[TBL] [Abstract][Full Text] [Related]
3. The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study).
Richardus RA; Alam K; Pahan D; Feenstra SG; Geluk A; Richardus JH
BMC Infect Dis; 2013 Oct; 13():456. PubMed ID: 24088534
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations of leprosy after BCG vaccination: an observational study in Bangladesh.
Richardus RA; Butlin CR; Alam K; Kundu K; Geluk A; Richardus JH
Vaccine; 2015 Mar; 33(13):1562-7. PubMed ID: 25701674
[TBL] [Abstract][Full Text] [Related]
5. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
Penna GO; Bührer-Sékula S; Kerr LRS; Stefani MMA; Rodrigues LC; de Araújo MG; Ramos AMC; de Andrade ARC; Costa MB; Rosa PS; Gonçalves HS; Cruz R; Barreto ML; Pontes MAA; Penna MLF
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005725. PubMed ID: 28704363
[TBL] [Abstract][Full Text] [Related]
6. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis.
Richardus JH; Oskam L
Clin Dermatol; 2015; 33(1):19-25. PubMed ID: 25432807
[TBL] [Abstract][Full Text] [Related]
7.
Hungria EM; Bührer-Sékula S; Oliveira RM; Aderaldo LC; Pontes MAA; Cruz R; de Gonçalves HS; Penna MLF; Penna GO; Stefani MMA
Front Immunol; 2018; 9():915. PubMed ID: 29867930
[TBL] [Abstract][Full Text] [Related]
8. The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis.
Schoenmakers A; Mieras L; Budiawan T; van Brakel WH
Res Rep Trop Med; 2020; 11():97-117. PubMed ID: 33117053
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention.
Schuring RP; Richardus JH; Pahan D; Oskam L
Vaccine; 2009 Nov; 27(50):7125-8. PubMed ID: 19786134
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial.
Moet FJ; Pahan D; Oskam L; Richardus JH;
BMJ; 2008 Apr; 336(7647):761-4. PubMed ID: 18332051
[TBL] [Abstract][Full Text] [Related]
11. Impact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort study.
Düppre NC; Camacho LA; Sales AM; Illarramendi X; Nery JA; Sampaio EP; Sarno EN; Bührer-Sékula S
PLoS Negl Trop Dis; 2012; 6(6):e1711. PubMed ID: 22724040
[TBL] [Abstract][Full Text] [Related]
12. The long-term effect of current and new interventions on the new case detection of leprosy: a modeling study.
Fischer EA; de Vlas SJ; Habbema JD; Richardus JH
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1330. PubMed ID: 21949895
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of chemoprophylaxis and immunoprophylaxis in leprosy prevention: a systematic review and network meta-analysis of randomized controlled trials.
Tawfik GM; Biala M; Yousef YM; Tiwari R; Dobs M; Lotfy CI; Farrag DA; Hue AT; Yotsu RR; Huy NT
Clin Microbiol Infect; 2021 Dec; 27(12):1754-1761. PubMed ID: 34332107
[TBL] [Abstract][Full Text] [Related]
14. Role of contact tracing and prevention strategies in the interruption of leprosy transmission.
Smith WC; Aerts A
Lepr Rev; 2014 Mar; 85(1):2-17. PubMed ID: 24974438
[TBL] [Abstract][Full Text] [Related]
15. A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP.
Moet FJ; Oskam L; Faber R; Pahan D; Richardus JH
Lepr Rev; 2004 Dec; 75(4):376-88. PubMed ID: 15682975
[TBL] [Abstract][Full Text] [Related]
16. Late relapses in leprosy patients in Brazil: 10-year post-trial of uniform multidrug therapy (U-MDT/CT-BR).
Penna GO; Pontes MAA; Talhari S; Gonçalves HS; Talhari C; Pessoa AS; Pedroza V; Bührer-Sékula S; Stefani MMA; Penna MLF
Braz J Infect Dis; 2024; 28(2):103745. PubMed ID: 38697216
[TBL] [Abstract][Full Text] [Related]
17. Interruption of persistent exposure to leprosy combined or not with recent BCG vaccination enhances the response to Mycobacterium leprae specific antigens.
de Carvalho FM; Rodrigues LS; Duppre NC; Alvim IMP; Ribeiro-Alves M; Pinheiro RO; Sarno EN; Pessolani MCV; Pereira GMB
PLoS Negl Trop Dis; 2017 May; 11(5):e0005560. PubMed ID: 28467415
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of rifampicin chemoprophylaxis in preventing leprosy in patient contacts: a systematic review of quantitative and qualitative evidence.
Ferreira SMB; Yonekura T; Ignotti E; Oliveira LB; Takahashi J; Soares CB
JBI Database System Rev Implement Rep; 2017 Oct; 15(10):2555-2584. PubMed ID: 29035966
[TBL] [Abstract][Full Text] [Related]
19. Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts.
Ortuno-Gutierrez N; Younoussa A; Randrianantoandro A; Braet S; Cauchoix B; Ramboarina S; Baco A; Mzembaba A; Salim Z; Amidy M; Grillone S; Richardus JH; de Jong BC; Hasker E
BMC Infect Dis; 2019 Dec; 19(1):1033. PubMed ID: 31805862
[TBL] [Abstract][Full Text] [Related]
20. Prevention of transmission of leprosy: The current scenario.
Palit A; Kar HK
Indian J Dermatol Venereol Leprol; 2020; 86(2):115-123. PubMed ID: 31975697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
